Cysteine, a facilitator of hypoxia adaptation and a promoter of drug-resistance : a new route to better diagnose and treat ovarian cancer patients
Ovarian cancer is the third most common gynaecologic malignancy and the main cause of death from gynaecologic cancer. Despite in the last 30 years an improvement of the overall survival of ovarian cancer patients has been observed, an increased cure rate was not registered. The high mortality associ...
| Autor principal: | |
|---|---|
| Formato: | doctoralThesis |
| Idioma: | eng |
| Publicado em: |
2019
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/68336 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/68336 |